Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Bioequivalence Study of Loxoprofen Sodium Patches in Chinese Healthy Volunteers

NCT06510413 is registered in ClinicalTrials.gov with Frontier Biotechnologies Inc. as lead sponsor.

NCT NCT06510413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06510413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Bioequivalence Study of Loxoprofen Sodium Patches in Chinese Healthy Volunteers
Lead sponsor
Frontier Biotechnologies Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2024
Completion date
August 31, 2024
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

muscle pain, osteoarthritis, swelling muscle